[Magnetic resonance in oncology].
The physical and biological background to magnetic resonance imaging (MRI) in patients with neoplasms is reviewed. The clinical indications for this method of diagnosis, staging, and follow-up of malignant neoplasms are discussed on the basis of the guidelines given by the MRI Consensus Conference on April 25-26, 1989, in Berne. MRI is the modality of choice in patients with neoplasms of the central nervous system and the musculoskeletal system. Further emerging indications for MRI are neoplasma of the ENT region, liver, and pelvic organs. Finally, the foreseeable developments in MRI and in magnetic resonance spectroscopy (MRS) are mentioned.
Terrier
F
F
Institut für Diagnostiche Radiologie, Universität, Inselspital Bern.
Schuknecht
B
B
Fretz
C
C
Vock
P
P
Herschkowitz
N
N
D000008:Abdominal Neoplasms / Q000175:diagnosis; D001932:Brain Neoplasms / Q000175:diagnosis; D005682:Gadolinium; D006258:Head and Neck Neoplasms / Q000175:diagnosis; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000639:trends; D009682:Magnetic Resonance Spectroscopy; D009362:Neoplasm Metastasis / Q000175:diagnosis*; D009369:Neoplasms / Q000175:diagnosis*; D010386:Pelvic Neoplasms / Q000175:diagnosis; D013125:Spinal Neoplasms / Q000175:diagnosis; D013899:Thoracic Neoplasms / Q000175:diagnosis
D005682:Gadolinium
Magnetische Resonanz in der Onkologie.